Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation

Clinical Biochemistry

Volumn 31, Issue 4, 1998, Pages 257-261

  Ahotupa, Markku ^a   Marniemi, Jukka ^b   Lehtimäki, Terho ^c   Talvinen, Kati ^a   Raitakari, Olli T ^d   Vasankari, Tommi ^a   Viikari, Jorma ^d   Luoma, Jukka ^e   Ylä Herttuala, Seppo ^e  

^a UNIVERSITY OF TURKU   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Atherosclerosis; Human serum; In vivo; Lipid peroxidation; Low density lipoprotein; Oxidation

Indexed keywords

HEPARIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIPID ANALYSIS; LIPID OXIDATION; LIPID PEROXIDATION; MALE; NORMAL HUMAN; PRECIPITATION; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

ADULT; FEMALE; HEPARIN; HUMANS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; OXIDATION-REDUCTION; PRECIPITATION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; ULTRACENTRIFUGATION;

EID: 0032100847     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00018-6     Document Type: Article

References (18)

1. 1. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-27.
2. 2. Witztum JL, Stein D. Role of oxidized LDL in atherogenesis. J Clin Invest 1991;88:1785-92.
3. 3. Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis:a clinical biochemistry perspective. Clin Chem 1996;42:498-506.
4. 4. Ahotupa M, Ruutu M, MäntyläE. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem 1996; 29:139-44.
5. 5. Wieland H, Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res 1983;24:904-9.
6. 6. Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. Methods Enzymol 1986;128: 155-68.
7. 7. Uusitupa MI, Niskanen L, Luoma J, et al. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16: 1236-42.
8. 8. Heitzer T, Ylä-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996;93: 1346-53.
9. 9. Ylä-Herttuala S, Rosenfield ME, Parthasarathy S, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
10. 10. O'Brien KD, Alpers CE, Hokanson JE, Wang S, Chait A. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein. Circulation 1996;94:1216-25.
11. 11. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
12. 12. Kappus H. Lipid peroxidation:mechanisms, analysis, enzymology and biological relevance. In:Sies H, Ed. Oxidative stress. London:Academic Press, 1985:273-310.
13. 13. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992;13: 341-90.
14. 14. Vasankari TJ, Kujala U, Vasankari TM, Vuorimaa T, Ahotupa M. Effects of acute prolonged exercise on serum and LDL oxidation antioxidant defences. Free Rad Biol Med 1997;22:509-13.
15. 15. Kujala UM, Ahotupa M, Vasankari T, Kaprio J, Tikkanen MJ. Low LDL oxidation in veteran endurance athletes. Scand J Med Sci Sports 1996;6:303-8.
16. 16. Vasankari T, Fogelholm M, Oja P, Vuori I, Ahotupa M. Effect of weight reduction on LDL oxidation (abstract). In:Väisänen S, Suomela-Markkanen T, Rankinen T, Eds. International 14th Puijo Symposium "Physical Activity, Diet and Cardiovascular Diseases A Fresh Look Beyond Old Facts, Publications of the University of Kuopio, Ser D Medicine 101, Kuopio, Finland, 1996, p. 37.
17. 17. Kujala UM, Ahotupa M, Vasankari T, Kaprio J, Tikkanen MJ. Familial aggregation of LDL oxidation. Scand J Clin Lab Invest 1997;57:141-6.
18. 18. Vasankari TJ, Kujala UM, Vasankari TM, Vuorimaa T, Ahotupa M. Increased serum LDL antioxidant potential after antioxidant supplementation in endurance athletes. Am J Clin Nutr 1997;65:1052-56.